Langley-based Adastra Holdings (CSE: XTRX) has walked back its original statement regarding its announcement of amended Controlled Drug and Substances Dealer’s License granted by Health Canada. In the original announcement on Feb. 22, CEO Michael Forbes stated that the company would “evaluate how the commercialization of this substance fits” with the firm’s business model. In the most … Continue reading Trudeau Clarifies Cocaine License “Not Permission To Sell Commercially” As Second BC Firm Secures License